PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-04-02

Date Title Company
02-Apr-2019 Celgene and Exscientia enter 3-year AI drug discovery collaboration focused on accelerating drug discovery in oncology and autoimmunity Celgene
02-Apr-2019 SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer SOTIO
02-Apr-2019 PDC*line Pharma enters into a licensing agreement with leading Korean pharmaceutical company LG Chem to develop PDC*lung cancer vaccine in Asia PDC*line Pharma
02-Apr-2019 Genomics plc analysis demonstrates potential for genomic data to identify those most at risk for 16 common diseases Genomics
02-Apr-2019 DISCOVERY PARK CHAIRMAN MARTINO PICARDO SHARES INSIGHT AT CONFERENCES Discovery Park
02-Apr-2019 International Brands Take to the Stage at ADF&PCD Shanghai 2019 ADF Conference
02-Apr-2019 Acorda to Present New Long-Term Data for INBRIJA™ (levodopa inhalation powder) at Academy of Managed Care Pharmacy Annual Meeting Acorda
02-Apr-2019 Cherwell Publishes Guide on Sterility Testing Cherwell
02-Apr-2019 Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster University Q BioMed
02-Apr-2019 PharmaLex selected as regulatory partner for 15m EUR EU Horizon project to design novel therapy PharmaLex
02-Apr-2019 Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance Veeva Systems
02-Apr-2019 Is your IBS actually undiagnosed coeliac disease? Coeliac UK
02-Apr-2019 Transgene secures a €20 Million Revolving Credit Facility with Natixis Transgene
02-Apr-2019 Verseon pioneers new way of funding innovation through security token offering Verseon
02-Apr-2019 Verseon announces security token offering to accelerate the development of its drug pipeline Verseon
02-Apr-2019 Amarin Schedules Webcast Discussion of Presented Data Today, March 18, 2019 at 4:00-5:00 pm CT Actelion Pharmaceuticals
02-Apr-2019 Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) Function and Pulmonary Vascular Resistance (PVR) in Patients with Pulmonary Arterial Hypertension (PAH) Actelion Pharmaceuticals
02-Apr-2019 Bulletin from Moberg Pharma’s Extraordinary General Meeting 15 March 2019 Moberg Pharma
02-Apr-2019 MICROSAIC SYSTEMS LAUNCHES BREAKTHROUGH PROTEIN CHARACTERISATION TECHNIQUE AT PITTCON 2019 MICROSAIC SYSTEMS
02-Apr-2019 Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale Cellesce